Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: J05AE

Faldaprevir Boehringer Ingelheim(faldaprevir)

Hepatitis C, Chronic

Marketing Authorisation Holder: Boehringer Ingelheim International GmbH

Indication

Treatment of chronic genotype-1 hepatitis C virus (HCV) infection.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Faldaprevir Boehringer Ingelheim — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.